We've found 10 total results for "Glaucoma".

PRESERFLO® MicroShunt Extension Study

This prospective, concurrent controlled, open-label, multicenter study is designed to collect additional safety data through 5 years of follow-up for subjects randomized to either the treatment arm (PRESERFLO® MicroShunt with MMC) or the control arm (Trabeculectomy wi...

Age: 40 - 85 years

Gender: All

Gaze-Evoked Intraocular Pressure Change in Glaucoma

The primary aim of this study is to evaluate the effect of upgaze on patients with POAG and NTG. Secondary aims of this study will include stratification based on severity of glaucoma or prior surgical interventions, and presence or absence of Bell’s phenomenon.

Age: 18 - 90 years

Gender: All

Macular Vessel Density and Foveal Avascular Zone Changes in Exfoliation Glaucoma vs Primary Open Angle Glaucoma vs Exfoliation Syndrome: An Optical Coherence Tomography Angiography Study

Glaucoma is an eye disease that results in damage to cells in the back of the eye known as the retina and poses a major risk to global public health. Primary open angle glaucoma (POAG) is the most common type of glaucoma in the United States. Exfoliation syndrome (XFS) ...

Age: 40 - 90 years

Gender: All

African Descent and Glaucoma Evaluation Study

According to the National Eye Institute, Glaucoma affects about three million Americans. Among Blacks in the United States, open- angle glaucoma is the leading cause of irreversible visual loss. Glaucoma is four times more likely to develop in Blacks than in Whites....

Age: 18 years - 66+

Gender: All

African Descent and Glaucoma Evaluation Study

According to the National Eye Institute, Glaucoma affects about three million Americans. Among Blacks in the United States, open- angle glaucoma is the leading cause of irreversible visual loss. Glaucoma is four times more likely to develop in Blacks than in Whites....

Age: 18 years - 66+

Gender: All